A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01 CA206978
National Cancer Institute
Grant: R01 CA216273
National Cancer Institute
Grant: U10 CA180861
National Cancer Institute
Grant: P01-CA081534
American Society of Hematology
Grant: R50CA251956-01
NCI NIH HHS
Grant: R00 CA190861
NCI NIH HHS
Grant: P01 CA081534
NCI NIH HHS
Grant: R50 CA251956
NCI NIH HHS
Grant: R01 CA240910
National Institutes of Health
Grant: 5P01CA081534-09
Immune Tolerance of CLL Antigens
National Institutes of Health
Grant: 5R01CA216273-04
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
National Institutes of Health
Grant: 1U10CA180861-01
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
National Institutes of Health
Grant: 5R50CA251956-05
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironment
National Institutes of Health
Grant: 5P01CA206978-05
Comprehensive dissection of the CLL genome and phenome to improve patient outcomes
Celgene
Janssen Pharmaceuticals
Leukemia and Lymphoma Society
TG Therapeutics
National Institutes of Health
Dana-Farber Cancer Institute
American Society of Hematology
Fondation de France
Gilead Sciences
University of California
Fields of Study
MeSH Terms
Keywords